List of Excipients in API MILNACIPRAN HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing MILNACIPRAN HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Allergan Inc | SAVELLA | milnacipran hydrochloride | 0456-1512 | CARBOXYMETHYLCELLULOSE CALCIUM | |
| Allergan Inc | SAVELLA | milnacipran hydrochloride | 0456-1512 | DIBASIC CALCIUM PHOSPHATE DIHYDRATE | |
| Allergan Inc | SAVELLA | milnacipran hydrochloride | 0456-1512 | FD&C BLUE NO. 2 | |
| Allergan Inc | SAVELLA | milnacipran hydrochloride | 0456-1512 | MAGNESIUM STEARATE | |
| Allergan Inc | SAVELLA | milnacipran hydrochloride | 0456-1512 | POLYETHYLENE GLYCOL | |
| Allergan Inc | SAVELLA | milnacipran hydrochloride | 0456-1512 | POLYVINYL ALCOHOL | |
| Allergan Inc | SAVELLA | milnacipran hydrochloride | 0456-1512 | POVIDONE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing MILNACIPRAN HYDROCHLORIDE
Detailed excipient profiles for MILNACIPRAN HYDROCHLORIDE
Excipient focus: CARBOXYMETHYLCELLULOSE CALCIUM
MILNACIPRAN HYDROCHLORIDE drug variants containing CARBOXYMETHYLCELLULOSE CALCIUM
MILNACIPRAN HYDROCHLORIDE drug variants not containing CARBOXYMETHYLCELLULOSE CALCIUM
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | milnacipran hydrochloride | 51991-034 |
| >Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
MILNACIPRAN HYDROCHLORIDE drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | milnacipran hydrochloride | 54868-6043 |
| >Company | >Ingredient | >NDC |
MILNACIPRAN HYDROCHLORIDE drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSPOVIDONE
MILNACIPRAN HYDROCHLORIDE drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | milnacipran hydrochloride | 51991-034 |
| >Company | >Ingredient | >NDC |
MILNACIPRAN HYDROCHLORIDE drug variants not containing CROSPOVIDONE
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
MILNACIPRAN HYDROCHLORIDE drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
MILNACIPRAN HYDROCHLORIDE drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | milnacipran hydrochloride | 31722-846 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
MILNACIPRAN HYDROCHLORIDE drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC | milnacipran hydrochloride | 35356-545 |
| Physicians Total Care Inc | milnacipran hydrochloride | 54868-6043 |
| >Company | >Ingredient | >NDC |
MILNACIPRAN HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
MILNACIPRAN HYDROCHLORIDE drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | milnacipran hydrochloride | 51991-034 |
| >Company | >Ingredient | >NDC |
MILNACIPRAN HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2
MILNACIPRAN HYDROCHLORIDE drug variants containing FD&C BLUE NO. 2
MILNACIPRAN HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE
MILNACIPRAN HYDROCHLORIDE drug variants containing FD&C BLUE NO. 2 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | milnacipran hydrochloride | 31722-846 |
| >Company | >Ingredient | >NDC |
MILNACIPRAN HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 2 ALUMINUM LAKE
Excipient focus: FD&C YELLOW NO. 5
MILNACIPRAN HYDROCHLORIDE drug variants containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC | milnacipran hydrochloride | 35356-545 |
| Physicians Total Care Inc | milnacipran hydrochloride | 54868-6043 |
| >Company | >Ingredient | >NDC |
MILNACIPRAN HYDROCHLORIDE drug variants not containing FD&C YELLOW NO. 5
Excipient focus: HYPROMELLOSE
MILNACIPRAN HYDROCHLORIDE drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | milnacipran hydrochloride | 51991-034 |
| >Company | >Ingredient | >NDC |
MILNACIPRAN HYDROCHLORIDE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
MILNACIPRAN HYDROCHLORIDE drug variants containing HYPROMELLOSES
MILNACIPRAN HYDROCHLORIDE drug variants not containing HYPROMELLOSES
Excipient focus: MAGNESIUM STEARATE
MILNACIPRAN HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE
MILNACIPRAN HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
MILNACIPRAN HYDROCHLORIDE drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | milnacipran hydrochloride | 31722-846 |
| >Company | >Ingredient | >NDC |
MILNACIPRAN HYDROCHLORIDE drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
MILNACIPRAN HYDROCHLORIDE drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | milnacipran hydrochloride | 31722-846 |
| >Company | >Ingredient | >NDC |
MILNACIPRAN HYDROCHLORIDE drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 112
MILNACIPRAN HYDROCHLORIDE drug variants containing MICROCRYSTALLINE CELLULOSE 112
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | milnacipran hydrochloride | 51991-034 |
| >Company | >Ingredient | >NDC |
MILNACIPRAN HYDROCHLORIDE drug variants not containing MICROCRYSTALLINE CELLULOSE 112
Excipient focus: POLYETHYLENE GLYCOL
MILNACIPRAN HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL
MILNACIPRAN HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | milnacipran hydrochloride | 31722-846 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
MILNACIPRAN HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | milnacipran hydrochloride | 31722-846 |
| >Company | >Ingredient | >NDC |
MILNACIPRAN HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYVINYL ALCOHOL
MILNACIPRAN HYDROCHLORIDE drug variants containing POLYVINYL ALCOHOL
MILNACIPRAN HYDROCHLORIDE drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
MILNACIPRAN HYDROCHLORIDE drug variants containing POVIDONE
MILNACIPRAN HYDROCHLORIDE drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | milnacipran hydrochloride | 31722-846 |
| Breckenridge Pharmaceutical Inc | milnacipran hydrochloride | 51991-034 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
MILNACIPRAN HYDROCHLORIDE drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | milnacipran hydrochloride | 31722-846 |
| >Company | >Ingredient | >NDC |
MILNACIPRAN HYDROCHLORIDE drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
MILNACIPRAN HYDROCHLORIDE drug variants containing SILICON DIOXIDE
MILNACIPRAN HYDROCHLORIDE drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | milnacipran hydrochloride | 54868-6043 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
MILNACIPRAN HYDROCHLORIDE drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | milnacipran hydrochloride | 31722-846 |
| >Company | >Ingredient | >NDC |
MILNACIPRAN HYDROCHLORIDE drug variants not containing SODIUM BICARBONATE
Excipient focus: TALC
MILNACIPRAN HYDROCHLORIDE drug variants containing TALC
MILNACIPRAN HYDROCHLORIDE drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | milnacipran hydrochloride | 51991-034 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
MILNACIPRAN HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE
MILNACIPRAN HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
MILNACIPRAN HYDROCHLORIDE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | milnacipran hydrochloride | 51991-034 |
| >Company | >Ingredient | >NDC |
MILNACIPRAN HYDROCHLORIDE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links